Universal CAR-γδT Cell Injection in the AML Patients
NCT05388305
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
AML
Interventions
BIOLOGICAL:
CAR--γδT cells
Sponsor
Hebei Senlang Biotechnology Inc., Ltd.